Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

E-Poster Display

1689P - The appropriateness of invasive ventilation in COVID-19 positive cancer patients: The hardest decision for oncologists

Date

17 Sep 2020

Session

E-Poster Display

Topics

COVID-19 and Cancer

Tumour Site

Presenters

Michele Ghidini

Citation

Annals of Oncology (2020) 31 (suppl_4): S934-S973. 10.1016/annonc/annonc289

Authors

M. Ghidini, A. Indini, E. Rijavec, C. Bareggi, M. Cattaneo, B. Galassi, D. Gambini, F. Grossi

Author affiliations

  • Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 - Milan/IT

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1689P

Background

Over the last two months we have frequently been contacted to estimate the prognosis of cancer patients (pts) affected by COVID-19 infection. Until now, there have been no clear markers to guide decision making regarding the appropriateness of invasive ventilation (IV) in COVID-19 cancer pts. Therefore, we developed a practical tool which encompasses a prognostic score in order to identify a subgroup of pts likely to have a better outcome and therefore may be potential candidates for IV.

Methods

The Milano Policlinico ONCOVID-ICU score includes three different groups of variables. In the first group we included sex, age, body mass index (BMI) and comorbidities. The second group includes oncological variables, such as the treatment intent (adjuvant or metastatic), life expectancy in months and treatment status (on/off). Furthermore, we included the SOFA score [1] and the d-dimer values, previously reported as risk factors for mortality in the presence of COVID-19 infection.

Results

We identified three different groups. We recommend that pts with a low risk score should be offered IV if necessary, while high-risk pts are best managed with best supportive care. Pts in the intermediate-risk group deserve a case-by-case discussion to derive a decision (Table). Table: 1689P

The Milano Policlinico ONCOVID-ICU score

Variables Score Categories of risk for pts
Linked to pts Score < 4: Low Risk ICU admission and IV. Score 4 - 6: Intermediate Risk Case-by-case evaluation for ICU admission and IV. Score >= 7: High Risk Palliative care.
Sex F = 0 M = 1
Age < 70 = 0 >= 70 = 1
BMI < 30 = 0 >= 30 = 1
Comorbidities NO = 0 YES = 1 YES > 1 = 2
Oncological
Treatment intent Curative = 0 Palliative = 1 SOFA SCORE [1] - PaO2/FIO2 (P/F) - Platelets - Bilirubin - Hypotension - Glasgow Coma Score Scale - Creatinine - Ventilatory support
Life expectancy < 6 mo = 0 > 6 mo = 1
Pts on treatment NO = 0 YES = 1
Clinical + lab values
SOFA score 2-7 = 0 >= 8 = 1
D-dimer < 1 μg/mL = 0 > 1 μg/mL = 1

Legend: BMI: body-mass index; F: female; FIO 2 : fraction of inspired oxigen; IV: invasive ventilation; M: male; mo: months; PaO 2 : partial pressure of oxigen; Pts: patients.

Conclusions

A considerable proportion of oncology pts may experience clinical deterioration due to the worsening course of the infection. These cases require a comprehensive evaluation before considering ICU admission and IV. The division between groups is arbitrary and the score needs further validation. Therefore, we plan to assess the clinical history of all cancer pts admitted to Milano Hospital Maggiore Policlinico’s ICU and retrospectively apply the score to this cohort. [1] Ferreira FL et al. JAMA 2001; 286:1754-8.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Financed by Italian fiscal contribution \"5x1000\" 2016 devolved to Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.